Literature DB >> 26684639

Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles.

Paola Pedata1, Claudia Petrarca2, Elpidio Maria Garzillo3, Mario Di Gioacchino4.   

Abstract

While nanotechnology is growing exponentially, the knowledge of the impact of nanoparticles (NPs) on public health and the environment is limited so far. Current nanomaterial research is focused on the applications of nanotechnology, whereas there is little information on exposure assessment and risk characterization associated with NPs. Therefore, it is essential that the factors influencing NPs associated hazards be studied. This review seeks to survey and evaluate the current literature in order to better understand the impact of both airborne and engineered NPs exposure, the mechanisms at the cellular level, and the factors influencing their immunotoxicity. In fact, NPs do have immunotoxicological significance, as immune cells in the bloodstream and tissues do act to eliminate or interact with NPs.Proper characterization of the NPs as well as understanding the processes occurring on the NPs surface when in contact with biological systems is crucial to predict or exclude toxicological effects.
© The Author(s) 2015.

Keywords:  environmental exposure; health effects; immunotoxicity; nanoparticle exposure; occupational exposure

Mesh:

Substances:

Year:  2015        PMID: 26684639      PMCID: PMC5806772          DOI: 10.1177/0394632015608933

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  92 in total

Review 1.  Inflammation caused by particles and fibers.

Authors:  Ken Donaldson; C Lang Tran
Journal:  Inhal Toxicol       Date:  2002-01       Impact factor: 2.724

2.  Migration of intradermally injected quantum dots to sentinel organs in mice.

Authors:  Neera V Gopee; Dean W Roberts; Peggy Webb; Christy R Cozart; Paul H Siitonen; Alan R Warbritton; William W Yu; Vicki L Colvin; Nigel J Walker; Paul C Howard
Journal:  Toxicol Sci       Date:  2007-04-02       Impact factor: 4.849

Review 3.  Inhaled nanoparticles--a current review.

Authors:  Wei Yang; Jay I Peters; Robert O Williams
Journal:  Int J Pharm       Date:  2008-02-16       Impact factor: 5.875

Review 4.  Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.

Authors:  Helinor Johnston; David Brown; Ali Kermanizadeh; Eva Gubbins; Vicki Stone
Journal:  J Control Release       Date:  2012-08-23       Impact factor: 9.776

5.  Interaction between combustion-generated organic nanoparticles and biological systems: in vitro study of cell toxicity and apoptosis in human keratinocytes.

Authors:  Paola Pedata; Mariarosaria Boccellino; Raffaele La Porta; Maria Napolitano; Patrizia Minutolo; Lee A Sgro; Francesca Zei; Nicola Sannolo; Lucio Quagliuolo
Journal:  Nanotoxicology       Date:  2011-05-16       Impact factor: 5.913

6.  Interaction with culture medium components, cellular uptake and intracellular distribution of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts.

Authors:  Enrico Sabbioni; Salvador Fortaner; Massimo Farina; Riccardo Del Torchio; Claudia Petrarca; Giovanni Bernardini; Renato Mariani-Costantini; Silvia Perconti; Luca Di Giampaolo; Rosalba Gornati; Mario Di Gioacchino
Journal:  Nanotoxicology       Date:  2012-12-21       Impact factor: 5.913

7.  Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption.

Authors:  P Filipe; J N Silva; R Silva; J L Cirne de Castro; M Marques Gomes; L C Alves; R Santus; T Pinheiro
Journal:  Skin Pharmacol Physiol       Date:  2009-08-18       Impact factor: 3.479

Review 8.  Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.

Authors:  Günter Oberdörster; Eva Oberdörster; Jan Oberdörster
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

9.  The potential risks of nanomaterials: a review carried out for ECETOC.

Authors:  Paul J A Borm; David Robbins; Stephan Haubold; Thomas Kuhlbusch; Heinz Fissan; Ken Donaldson; Roel Schins; Vicki Stone; Wolfgang Kreyling; Jurgen Lademann; Jean Krutmann; David Warheit; Eva Oberdorster
Journal:  Part Fibre Toxicol       Date:  2006-08-14       Impact factor: 9.400

10.  Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytes.

Authors:  Christiane Eder; Marion Frankenberger; Franz Stanzel; Albrecht Seidel; Karl-Werner Schramm; Loems Ziegler-Heitbrock; Thomas Pj Hofer
Journal:  Part Fibre Toxicol       Date:  2009-10-16       Impact factor: 9.400

View more
  5 in total

Review 1.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

Review 2.  Effects of engineered nanoparticles on the innate immune system.

Authors:  Yuanchang Liu; Joseph Hardie; Xianzhi Zhang; Vincent M Rotello
Journal:  Semin Immunol       Date:  2017-10-04       Impact factor: 11.130

Review 3.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

4.  Nanomedicinal products: a survey on specific toxicity and side effects.

Authors:  Walter Brand; Cornelle W Noorlander; Christina Giannakou; Wim H De Jong; Myrna W Kooi; Margriet Vdz Park; Rob J Vandebriel; Irene Em Bosselaers; Joep Hg Scholl; Robert E Geertsma
Journal:  Int J Nanomedicine       Date:  2017-08-22

5.  Enhancing innate antiviral immune responses in rainbow trout by double stranded RNA delivered with cationic phytoglycogen nanoparticles.

Authors:  Tamiru N Alkie; Jondavid de Jong; Kristof Jenik; Karl M Klinger; Stephanie J DeWitte-Orr
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.